Conference Coverage

Step-down etanercept fails to control ankylosing spondylitis

Publish date: May 5, 2014

 

AT RHEUMATOLOGY 2014

The study was funded by Pfizer. Dr. Gaffney has received research support and honoraria from Pfizer, Merck Sharp & Dohme, AbbVie, and UCB.

Pages

Recommended Reading

Stopping biologics in RA remission remains uncertain
MDedge Internal Medicine
Current smoking strongly predicts rheumatoid arthritis radiographic progression
MDedge Internal Medicine
VIDEO: Practice pearls for treating opiate dependence
MDedge Internal Medicine
Chinese herbal remedy found noninferior to methotrexate in RA patients
MDedge Internal Medicine
Sprifermin injections showed some benefits for cartilage loss in knee osteoarthritis
MDedge Internal Medicine
Men have more major complications after hip, knee replacement
MDedge Internal Medicine
PCPs waffle in referrals for total joint replacement
MDedge Internal Medicine
Intraoperative wound anesthetic cut chronic pain after hip replacement
MDedge Internal Medicine
OA-related walking disability on par with diabetes as CVD risk factor
MDedge Internal Medicine
Anti-TNFs linked to lower heart attack risk in RA patients
MDedge Internal Medicine